Released Nov 3, 2015, after the close
10-Q filed Nov 3, 2015, 34 days after period end · 0001564590-15-009166
Q3 2015 · 10-Q
Revenue$101.15M$101.15M +0.2% vs Q3 2014+0.2% vs Q2 2015
Net Income-$1.37M-$1.37M N/M vs Q3 2014N/M vs Q2 2015
EPS Diluted-$0.07-$0.07 N/M vs Q3 2014N/M vs Q2 2015
Gross Profit$77,286,000+2.1%
Operating Income$4,139,000−36.4%
Operating Cash Flowderived$17,585,000−2.8%
Free Cash Flowderived$10,098,000−21.8%
Margins · derived
Gross margin76.4%+1.4 pt vs Q3 2014
Operating margin4.1%−2.4 pt vs Q3 2014
Net margin-1.4%−1.8 pt vs Q3 2014
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2015 | Q3 2014 | Q3 2013 | Q3 2012 |
|---|---|---|---|---|
| Revenue | $101.15M | $100.99M | $91.81M | $105.82M |
| Net Income | -$1.37M | $452.00K | -$18.84M | $3.75M |
| EPS Diluted | -$0.07 | $0.02 | -$1.04 | $0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR